Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Aug. 31, 2020 |
Aug. 31, 2019 |
Aug. 31, 2020 |
Aug. 31, 2019 |
|
| Research and development expenses | $ 2,749,222 | $ 970,213 | $ 4,229,810 | $ 1,968,074 |
| Stock Options | ||||
| Antidilutive securities | 1,590,470 | 1,657,081 | ||
| Restricted Stock Units | ||||
| Antidilutive securities | 4,313,750 | 4,419,753 | ||
| Warrants | ||||
| Antidilutive securities | 4,884,331 | 5,040,267 | ||